tradingkey.logo
tradingkey.logo
Pesquisar

Anbio Biotechnology

NNNN
Adicionar à lista de desejos
12.700USD
+0.355+2.88%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
557.42MValor de mercado
86.61P/L TTM

Mais detalhes de Anbio Biotechnology Empresa

Anbio Biotechnology is a Germany-based medical device company. The Company is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).

Informações de Anbio Biotechnology

Código da empresaNNNN
Nome da EmpresaAnbio Biotechnology
Data de listagemFeb 19, 2025
CEOLau (Michael)
Número de funcionários27
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 19
EndereçoFriedrich-Ebert-Anlage 49
CidadeFRANKFURT AM MAIN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísGermany
Código postal60308
Telefone4916096247281
Sitehttps://anbiobiotechnology.com/
Código da empresaNNNN
Data de listagemFeb 19, 2025
CEOLau (Michael)

Executivos da empresa Anbio Biotechnology

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael Lau
Mr. Michael Lau
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Suki Song
Ms. Suki Song
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Tiantian
Mr. Chris Tiantian
Chief Business Officer
Chief Business Officer
--
--
Mr. Cany Xu
Mr. Cany Xu
Executive Director
Executive Director
--
--
Ms. Nancy Hartzler
Ms. Nancy Hartzler
Independent Director
Independent Director
--
--
Mr. Kenneth Li
Mr. Kenneth Li
Independent Director
Independent Director
--
--
Mr. David Hsu
Mr. David Hsu
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael Lau
Mr. Michael Lau
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Suki Song
Ms. Suki Song
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Tiantian
Mr. Chris Tiantian
Chief Business Officer
Chief Business Officer
--
--
Mr. Cany Xu
Mr. Cany Xu
Executive Director
Executive Director
--
--
Ms. Nancy Hartzler
Ms. Nancy Hartzler
Independent Director
Independent Director
--
--
Mr. Kenneth Li
Mr. Kenneth Li
Independent Director
Independent Director
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Anbio Biotechnology?

Os cinco principais acionistas de Anbio Biotechnology são: Mr. Michael Lau

Quantas instituições possuem ações da Anbio Biotechnology (NNNN)?

Em 2026Q1, 13 instituições possuíam ações da Anbio Biotechnology, com valor de mercado aproximado de 2.13M, representando 4.86% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 2063041.00.